Logo image of HOLX

HOLOGIC INC (HOLX) Stock Price, Forecast & Analysis

USA - NASDAQ:HOLX - US4364401012 - Common Stock

74.15 USD
-0.11 (-0.15%)
Last: 11/14/2025, 8:00:01 PM
74.16 USD
+0.01 (+0.01%)
After Hours: 11/14/2025, 8:00:01 PM

HOLX Key Statistics, Chart & Performance

Key Statistics
Market Cap16.49B
Revenue(TTM)4.10B
Net Income(TTM)565.80M
Shares222.42M
Float220.51M
52 Week High80.31
52 Week Low51.9
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)4.27
PE17.37
Fwd PE16.09
Earnings (Next)02-03 2026-02-03/amc
IPO1990-03-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


HOLX short term performance overview.The bars show the price performance of HOLX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

HOLX long term performance overview.The bars show the price performance of HOLX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 2 -2 -4

The current stock price of HOLX is 74.15 USD. In the past month the price increased by 6.16%. In the past year, price decreased by -5.66%.

HOLOGIC INC / HOLX Daily stock chart

HOLX Latest News, Press Relases and Analysis

HOLX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.17 227.29B
ISRG INTUITIVE SURGICAL INC 63.82 196.99B
BSX BOSTON SCIENTIFIC CORP 34.81 152.16B
SYK STRYKER CORP 27.5 138.48B
BDX BECTON DICKINSON AND CO 13.39 55.33B
IDXX IDEXX LABORATORIES INC 54.71 55.19B
EW EDWARDS LIFESCIENCES CORP 33.58 50.67B
RMD RESMED INC 24.69 35.68B
GEHC GE HEALTHCARE TECHNOLOGY 15.94 33.40B
PODD INSULET CORP 72.8 23.42B
DXCM DEXCOM INC 31.22 22.77B
ZBH ZIMMER BIOMET HOLDINGS INC 11.11 17.81B

About HOLX

Company Profile

HOLX logo image Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.

Company Info

HOLOGIC INC

250 Campus Drive

Marlborough MASSACHUSETTS 01752 US

CEO: STEPHEN P. MACMILLAN

Employees: 7063

HOLX Company Website

HOLX Investor Relations

Phone: 15082632900

HOLOGIC INC / HOLX FAQ

Can you describe the business of HOLOGIC INC?

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women’s health and well-being through early detection and treatment. The company is headquartered in Marlborough, Massachusetts and currently employs 7,063 full-time employees. The firm is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.


Can you provide the latest stock price for HOLOGIC INC?

The current stock price of HOLX is 74.15 USD. The price decreased by -0.15% in the last trading session.


Does HOLOGIC INC pay dividends?

HOLX does not pay a dividend.


How is the ChartMill rating for HOLOGIC INC?

HOLX has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.


What is the GICS sector and industry of HOLX stock?

HOLOGIC INC (HOLX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is HOLOGIC INC worth?

HOLOGIC INC (HOLX) has a market capitalization of 16.49B USD. This makes HOLX a Large Cap stock.


What is the ownership structure of HOLOGIC INC (HOLX)?

You can find the ownership structure of HOLOGIC INC (HOLX) on the Ownership tab.


HOLX Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to HOLX. When comparing the yearly performance of all stocks, HOLX turns out to be only a medium performer in the overall market: it outperformed 52.34% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

HOLX Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to HOLX. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

HOLX Financial Highlights

Over the last trailing twelve months HOLX reported a non-GAAP Earnings per Share(EPS) of 4.27. The EPS increased by 4.66% compared to the year before.


Industry RankSector Rank
PM (TTM) 13.8%
ROA 6.28%
ROE 11.21%
Debt/Equity 0.5
Chartmill High Growth Momentum
EPS Q2Q%11.88%
Sales Q2Q%6.24%
EPS 1Y (TTM)4.66%
Revenue 1Y (TTM)1.74%

HOLX Forecast & Estimates

25 analysts have analysed HOLX and the average price target is 75.7 USD. This implies a price increase of 2.09% is expected in the next year compared to the current price of 74.15.

For the next year, analysts expect an EPS growth of 7.91% and a revenue growth 4.54% for HOLX


Analysts
Analysts70.4
Price Target75.7 (2.09%)
EPS Next Y7.91%
Revenue Next Year4.54%

HOLX Ownership

Ownership
Inst Owners100.94%
Ins Owners0.78%
Short Float %1.59%
Short Ratio1.28